tradmap

BRKR Bruker Corp

$57.20 +4.51%

Healthcare · Laboratory Analytical Instruments

Bruker Corp (BRKR) is a healthcare company in the Laboratory Analytical Instruments industry, with a market capitalization of $8.7 billion. Shares last traded at $57.20, 11.4% below their 52-week high. Over the past year the stock is up 52.1%. Net profit margin is -0.2%, above the peer median of -1.5%. Revenue grew 2.1% year over year. The shares yield 0.4% in dividends.

Market Cap
$8.7B
Shares Out
152.2M
EPS (TTM)
$0.04
P/E Ratio
1430.00
P/S Ratio
2.53
P/B Ratio
3.53
Dividend / Share
$0.25
Dividend Yield
0.44%
52-Week High
$64.53
52-Week Low
$28.61
Volume
87,910
Avg Vol (3m)
147,943.667

Performance

1W
+3.68%
1M
+34.35%
3M
+70.14%
6M
+27.24%
YTD
+18.88%
1Y
+52.09%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
61.48
SMA (50)
$45.95
SMA (200)
$41.86
Price vs SMA50
+24.47%
Price vs SMA200
+36.64%
ATR (14)
$2.86

Financials

Revenue
$3.4B
Net Income
$-8M
Gross Margin
45.9%
Operating Margin
2.0%
Net Margin
-0.2%
Return on Equity
-0.3%
Return on Assets
-0.1%
Current Ratio
1.55
Debt / Equity
0.68
Revenue Growth (YoY)
+2.1%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.02 2026-05-07
FY 2025 $-0.15 2026-02-27
Q3 2025 $-0.25 2025-11-05
Q2 2025 $0.16 2025-08-06
Q1 2026 $0.11 2026-05-07
FY 2025 $0.76 2026-02-27

Full earnings history →

Laboratory Analytical Instruments peers

BRKR vs 14 industry peers (Laboratory Analytical Instruments), by market cap.

P/S vs peers
2.53 / 2.95 med
-14% discount
Net margin vs peers
-0.2% / -1.5% med
above median
1–14 of 14
AAgilent Technologies$35.9B27.555.1718.8%+2.23%
WATWaters Corporation$34.9B54.3211.0320.3%-0.44%
ILMNIllumina, Inc.$24.5B28.805.6419.6%+1.68%
MTDMettler Toledo$23.1B26.595.7421.6%+1.22%
RVTYRevvity$11.1B46.223.908.4%+2.23%
BRKRBruker Corp$8.7B-1049.062.53-0.2%+4.51%
BIOBio-Rad Laboratories, Inc.$7.6B10.022.9529.4%-0.80%
AVTRAvantor, Inc.$6.5B-12.321.00-8.1%+1.16%
TXG10x Genomics, Inc.$4.5B-102.516.94-6.8%+8.24%
ALMRAlamar Biosciences, Inc.$1.5B+8.56%
EYPTEyepoint, Inc.$1.1B-4.91+3.35%
CTKBCytek Biosciences, Inc.$488M-7.342.42-33.0%-4.91%
PACBPacific Biosciences Of California, Inc.$432M-0.79+3.35%
LABSTANDARD BIOTOOLS INC.$324M-4.323.79-87.8%+2.65%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.